CV CapsoVision, Inc.

$6.60▲ +1.23% Healthcare Other
After hours $6.56▼ -0.61% Sep 11, 7:30 PM ET
Volume 207.1K Avg Volume (10D) 117.9K
Key Metrics & Fundamentals
Market Cap
$330.31M
P/E Ratio
–
Div Yield
–%
52W Range
3.60 - 15.37
% vs 50 MA
3.05%
% vs 200 MA
-3.11%
RSI-14
59.2
MACD Histogram
+0.0900
Beta (1Y vs SPY)
0.78
Free Cash Flow
-$8.40M
Gross Rev
$3.64M
Gross Profit
$1.87M
EBITDA
-$7.42M
COGS
$1.77M
Operating Exp
$9.45M
Operating Income
-$7.58M
EBIT
-$7.58M
Pretax Income
-$7.48M
Net Income
-$7.48M
EPS (Diluted)
-0.15
Price & Volume History
Loading chart…
Recent News
CapsoVision to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 8:05 PM
Outlook Therapeutics Appoints Kevin Lundquist as CFO
MT Newswires · Aug 27, 2026 8:39 PM
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ...
GuruFocus.com · Aug 14, 2026 5:01 AM
CapsoVision Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 11:04 PM
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities
MT Newswires · Aug 13, 2026 9:18 PM
CapsoVision Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 8:05 PM
CapsoVision® Announces International Launch of AI Highlights
GlobeNewswire · Aug 3, 2026 8:30 PM
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
GlobeNewswire · Jul 30, 2026 8:05 PM
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
GlobeNewswire · Jul 2, 2026 8:05 PM
Financial Overview - Income Statement Quarterly

See CV's money flow as a full page

Social Sentiment
Avg +0.35 · 4 posts
Sanofi’s latest SEC filing omits a $15B federal case, then raises $3B in bonds days later
r/stocks · Nov 4, 2025
The post highlights a concerning legal issue and subsequent bond issuance, suggesting potential financial strain on Sanofi.
negative -0.60
DiscussionAi CV edit app
r/options · Oct 18, 2025
The post promotes a useful tool with AI features, suggesting a positive sentiment.
positive +0.60
FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk
r/stocks · Oct 17, 2025
The post expresses optimism about NVO's stock potential following the approval, indicating a bullish sentiment.
positive +0.60
NewsEarningsPriceTargetTradeCapsoVision Trading started $CV
r/wallstreetbets · Jul 2, 2025
The post discusses the company's IPO announcement, indicating a potential positive outlook.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙